lower-vitamin-d-and-magnesium-levels-track-degenerative-temporomandibular-disorders
Lower Vitamin D and Magnesium Levels Track Degenerative Temporomandibular Disorders

Lower Vitamin D and Magnesium Levels Track Degenerative Temporomandibular Disorders

Lower serum concentrations of 25-hydroxyvitamin D and magnesium are significantly associated with cone-beam computed tomography-documented osseous degeneration among patients diagnosed with temporomandibular disorders, according to a single-centre prospective cross-sectional study published in Head & Face Medicine. The clinical evaluation established that individuals presenting with degenerative joint alterations exhibited marked reductions in both circulation markers compared to symptomatic temporomandibular disorder patients who showed no detectable osseous degeneration on radiographic imaging.

Circulating bone and mineral metabolism markers, particularly vitamin D, have previously been linked to temporomandibular disorders, but their relationship to objectively verified articular degradation has rarely been examined. To address this gap, researchers investigated whether circulating bone and mineral metabolism markers differ systematically between temporomandibular disorder patients with and without cone-beam computed tomography-documented osseous degeneration, while also evaluating whether marker concentrations track with the severity of condylar erosion.

The study protocol enrolled a total of one hundred consecutively recruited temporomandibular disorder patients divided into two comparative cohorts. Sixty patients presented with degenerative joint disease that was objectively confirmed through cone-beam computed tomography imaging. The comparative group comprised forty symptomatic temporomandibular disorder patients who presented without detectable osseous degeneration upon cone-beam computed tomography scanning.

Serum analyses evaluated concentrations of 25-hydroxyvitamin D, magnesium, parathyroid hormone, calcium, phosphorus, and alkaline phosphatase across all participants. The primary markers of interest were specified as 25-hydroxyvitamin D, an established candidate marker, and magnesium, which served as the novel candidate marker under investigation. All additional laboratory comparisons were designated as secondary or exploratory analyses. Intergroup differences were assessed using appropriate parametric or non-parametric tests, alongside a Firth penalized logistic regression model that adjusted for age and sex.

Laboratory findings revealed substantial intergroup disparities in circulating mineral markers. Patients in the degenerative group demonstrated significantly lower serum 25-hydroxyvitamin D levels, averaging 16.4 ng/mL compared to 25.6 ng/mL in the non-degenerative cohort, alongside lower serum magnesium concentrations averaging 1.66 mg/dL versus 2.00 mg/dL. Conversely, serum parathyroid hormone was significantly higher in patients with degenerative disease. Statistical significance was documented for 25-hydroxyvitamin D (p < 0.001), magnesium (p < 0.001), and parathyroid hormone (p = 0.005), whereas serum calcium levels showed no difference between the cohorts. Furthermore, zero patients with degenerative joint disease were classified as vitamin D-sufficient, whereas patients in the comparison group were predominantly insufficient.

Multivariable evaluation using Firth penalized logistic regression demonstrated that lower 25-hydroxyvitamin D and lower magnesium remained independently associated with joint degeneration after adjusting for age and sex, with 25-hydroxyvitamin D showing the strongest association. Parathyroid hormone did not retain a statistically significant association with degeneration following multivariable adjustment. Within the degenerative patient subset, condylar erosion severity demonstrated an inverse correlation with 25-hydroxyvitamin D concentrations and a positive correlation with parathyroid hormone levels; magnesium levels successfully differentiated the two clinical cohorts but exhibited no gradient across erosion severity tiers.

The investigators emphasized that contrasting degenerative patients against symptomatic non-degenerative patients helps reduce confounding arising from the presence of temporomandibular disorders themselves. However, the study cohorts also exhibited differing DC/TMD profiles, and multivariable adjustment was constrained to age and sex only. Because the study utilized a cross-sectional methodology, the observed associations cannot establish causal relationships and do not support clinical screening or therapeutic recommendations. Instead, the authors concluded that these findings identify systemic bone and mineral metabolism as a hypothesis requiring confirmation in future prospective evaluations of temporomandibular joint osteoarthritis.

Subject of Research: Serum bone and mineral metabolism markers in degenerative temporomandibular disorders

Article Title: Serum bone and mineral metabolism markers in CBCT-confirmed degenerative versus non-degenerative temporomandibular disorders

Article References: Altundal, G., Zorlu, E., Yüce, F., Altundal, Y. E., & Biren, S. (2026). Serum bone and mineral metabolism markers in CBCT-confirmed degenerative versus non-degenerative temporomandibular disorders. Head & Face Medicine. https://doi.org/10.1186/s13005-026-00657-3

Image Credits: AI Generated

DOI: 10.1186/s13005-026-00657-3

Keywords: temporomandibular disorders, cone-beam computed tomography, 25-hydroxyvitamin D, magnesium, parathyroid hormone, bone metabolism, mineral metabolism, degenerative joint disease, condylar erosion, temporomandibular joint osteoarthritis, calcium, phosphorus, alkaline phosphatase, cross-sectional study, Firth penalized logistic regression, DC/TMD profiles